Use of the novel combined contraceptive vaginal ring NuvaRing for ovulation inhibition

By Mulders T.M.T.   Dieben T.O.M.  

Fertility and Sterility, Vol. 75, Iss. 5, 2001-05 ,pp. : 865-870

Elsevier

Access to resources Recommend Favorite

The combined contraceptive vaginal device (NuvaRing®): A comprehensive review

By Sarkar NN  

The European Journal of Contraception and Reproductive Health Care, Vol. 10, Iss. 2, 2005-06 ,pp. : 73-78

Informa Healthcare

Access to resources Recommend Favorite

Clinical experience with NuvaRing® in daily practice in Switzerland: Cycle control and acceptability among women of all reproductive ages

By Merki-Feld Gabriele S.   Hund Martin  

The European Journal of Contraception and Reproductive Health Care, Vol. 12, Iss. 3, 2007-01 ,pp. : 240-247

Informa Healthcare

Access to resources Recommend Favorite

The contraceptive vaginal ring, NuvaRing^®, a decade after its introduction

By Roumen Frans J. M. E.   Mishell Daniel R.  

The European Journal of Contraception and Reproductive Health Care, Vol. 17, Iss. 6, 2012-12 ,pp. : 415-427

Informa Healthcare

Access to resources Recommend Favorite

A comparative study on the effects of a contraceptive vaginal ring NuvaRing^® and an oral contraceptive on carbohydrate metabolism and adrenal and thyroid function

By Duijkers I   Killick S   Bigrigg A   Dieben Tom  

The European Journal of Contraception and Reproductive Health Care, Vol. 9, Iss. 3, 2004-09 ,pp. : 131-140

Informa Healthcare

Access to resources Recommend Favorite